DCVC Opportunity Fund II GP
Latest statistics and disclosures from DCVC Opportunity Fund II GP's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RXRX, IONQ, and represent 100.00% of DCVC Opportunity Fund II GP's stock portfolio.
- Reduced shares in these 1 stock: IONQ.
- DCVC Opportunity Fund II GP was a net seller of stock by $-507k.
- DCVC Opportunity Fund II GP has $17M in assets under management (AUM), dropping by 24.05%.
- Central Index Key (CIK): 0001668343
Tip: Access up to 7 years of quarterly data
Positions held by DCVC Opportunity Fund II GP consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for DCVC Opportunity Fund II GP
DCVC Opportunity Fund II GP holds 2 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals Cl A (RXRX) | 84.3 | $15M | 4.0M | 3.67 |
|
|
| IonQ Cl A (IONQ) | 15.7 | $2.7M | -15% | 51k | 53.26 |
|
Past Filings by DCVC Opportunity Fund II GP
SEC 13F filings are viewable for DCVC Opportunity Fund II GP going back to 2026
- DCVC Opportunity Fund II GP 2026 Q2 filed Aug. 14, 2026
- DCVC Opportunity Fund II GP 2026 Q1 filed May 15, 2026